Amigo’s (AMGO) Outperform Rating Reiterated at Royal Bank of Canada

Share on StockTwits

Amigo (LON:AMGO)‘s stock had its “outperform” rating reaffirmed by Royal Bank of Canada in a report issued on Thursday. They presently have a GBX 345 ($4.51) target price on the stock. Royal Bank of Canada’s price objective suggests a potential upside of 28.25% from the stock’s previous close.

Several other research firms have also recently weighed in on AMGO. Macquarie initiated coverage on Amigo in a research report on Thursday, August 9th. They issued an “outperform” rating and a GBX 350 ($4.57) price objective for the company. Numis Securities cut Amigo to an “add” rating in a research report on Thursday, August 30th. Berenberg Bank initiated coverage on Amigo in a research report on Tuesday, October 30th. They issued a “hold” rating and a GBX 240 ($3.14) price objective for the company. Shore Capital reissued a “hold” rating on shares of Amigo in a research report on Tuesday, November 27th. Finally, JPMorgan Chase & Co. initiated coverage on Amigo in a research report on Thursday, August 9th. They issued an “overweight” rating and a GBX 335 ($4.38) price objective for the company. Three analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of GBX 307.50 ($4.02).

AMGO opened at GBX 269 ($3.51) on Thursday.

Amigo Company Profile

Amigo Holdings PLC, through its subsidiaries, provides guarantor loans to individuals in the United Kingdom. The company was founded in 2005 and is based in Bournemouth, the United Kingdom. Amigo Holdings PLC is a subsidiary of Richmond Group Limited.

See Also: How analysts view the yield curve

Analyst Recommendations for Amigo (LON:AMGO)

Receive News & Ratings for Amigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amigo and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.